4//SEC Filing
Ralhan Sameer 4
Accession 0001627223-22-000040
CIK 0001627223other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 6:21 PM ET
Size
13.9 KB
Accession
0001627223-22-000040
Insider Transaction Report
Form 4
Ralhan Sameer
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2022-05-06$40.14/sh−35,188$1,412,446→ 313,506.226 total - Exercise/Conversion
Common Stock
2022-05-09$5.40/sh+20,175$108,945→ 333,681.226 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-06−35,188→ 20,175 totalExercise: $5.40Exp: 2026-03-01→ Common Stock (35,188 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-09−20,175→ 0 totalExercise: $5.40Exp: 2026-03-01→ Common Stock (20,175 underlying) - Exercise/Conversion
Common Stock
2022-05-06$5.40/sh+35,188$190,015→ 348,694.226 total - Sale
Common Stock
2022-05-09$40.01/sh−20,175$807,202→ 313,506.226 total
Footnotes (4)
- [F1]Includes directly owned shares, restricted stock units, and dividend equivalent units.
- [F2]Shares were sold in multiple transactions at prices ranging from $40.00 to $40.32.
- [F3]Shares were sold in multiple transactions at prices ranging from $40.00 to $40.06.
- [F4]Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.
Documents
Issuer
Chemours Co
CIK 0001627223
Entity typeother
Related Parties
1- filerCIK 0001778813
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 6:21 PM ET
- Size
- 13.9 KB